Journal ArticleCirculation · April 2025
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes in hearts recovered from extended-criteria d ...
Full textLink to itemCite
Journal ArticleASAIO J · March 6, 2025
Outflow graft obstruction (OGO) is an under-reported but severe complication after insertion of magnetically levitated centrifugal-flow left ventricular assist devices (LVADs). The optimal treatment and long-term outcomes have not been well-described. We r ...
Full textLink to itemCite
Journal ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · March 2025
BackgroundContemporary durable left ventricular assist devices (LVAD) have established current benchmarks for patient outcomes, but introduction of more novel technology is lacking. The BrioVAD System (BrioHealth Solutions, Burlington, MA) is an i ...
Full textCite
Journal ArticleHeart Rhythm · February 2025
BACKGROUND: Implantable cardioverter-defibrillator (ICD) shocks are a common complication after left ventricular assist device (LVAD) implantation; however, data on their frequency and causes are limited. OBJECTIVE: The purpose of this study was to define ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 9, 2024
BACKGROUND: Normothermic regional perfusion (NRP) and direct procurement and perfusion (DPP) allow for transplantation with donation after circulatory death (DCD) hearts. This study aimed to characterize the use of and variations in NRP and DPP for DCD tra ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · December 2024
BACKGROUND: Heart transplantation following donation after circulatory death (DCD HT) has short-term survival outcomes comparable to donation after brain death and has led to a significant increase in transplantation volume. The U.S. experience with the no ...
Full textLink to itemCite
ConferenceJTCVS Open · December 2024
OBJECTIVE: The transplantation of hearts from donors who experienced intracranial bleeding (ICB) has been associated with inferior long-term survival in both single-center analyses and, more recently, with the United Network for Ogan Sharing Registry. The ...
Full textLink to itemCite
Journal ArticleJTCVS Open · October 2024
OBJECTIVE: Randomized data support transplantation of hearts from donors after circulatory death. This may lead to a sizeable increase in the donor pool. Regional variations in donors after circulatory death heart use were examined to help elucidate barrie ...
Full textLink to itemCite
ConferenceJTCVS Open · October 2024
OBJECTIVE: Biologic valves dominate tricuspid valve replacement, yet data on different valve types are lacking. We compare the survival and durability of porcine and pericardial tricuspid prostheses. METHODS: A retrospective review of consecutive patients ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · September 21, 2024
BACKGROUND: We previously reported that concurrent tricuspid valve surgery (TVS) was not associated with a lower incidence of early right heart failure (RHF) in patients undergoing durable left ventricular assist device (LVAD) implantation. This follow-up ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · September 2024
Left ventricular assist devices (LVADs) are excellent therapies for advanced heart failure patients either bridged to transplant or for lifetime use. LVADs also allow for reverse remodeling of the failing heart that is often associated with functional impr ...
Full textLink to itemCite
Journal ArticleJTCVS Open · June 1, 2024
Objective: There is a paucity of data assessing the impact of nutritional status on outcomes in patients supported with the HeartMate 3 (HM3) left ventricular assist device (LVAD). Methods: Patients ≥18 years of age who underwent HM3 LVAD implantation betw ...
Full textCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2024
OBJECTIVES: Right heart failure remains a serious complication of left ventricular assist device therapy. Many patients presenting for left ventricular assist device implantation have significant tricuspid regurgitation. It remains unknown whether concurre ...
Full textLink to itemCite
ConferenceJ Heart Lung Transplant · May 2024
BACKGROUND: Cardiac metabolism is altered in heart failure and ischemia-reperfusion injury states. We hypothesized that metabolomic profiling during ex situ normothermic perfusion before heart transplantation (HT) would lend insight into myocardial substra ...
Full textLink to itemCite
Journal ArticleInfect Control Hosp Epidemiol · May 2024
BACKGROUND: Various water-based heater-cooler devices (HCDs) have been implicated in nontuberculous mycobacteria outbreaks. Ongoing rigorous surveillance for healthcare-associated M. abscessus (HA-Mab) put in place following a prior institutional outbreak ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · May 2024
BACKGROUND: Heart transplant (HT) in recipients with left ventricular assist devices (LVADs) is associated with poor early post-HT outcomes, including primary graft dysfunction (PGD). As complicated heart explants in recipients with LVADs may produce longe ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · May 2024
BACKGROUND: Postoperative atrial fibrillation (POAF) is associated with increased morbidity and mortality. Epicardial injection of botulinum toxin may suppress POAF. OBJECTIVES: This study sought to assess the safety and efficacy of AGN-151607 for the prev ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2024
Historically, heart transplantation (HT) has relied on the use of traditional cold storage for donor heart preservation. This organ preservation modality has several limitations, including the risk for ischemic and cold-induced graft injuries that may cont ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · March 2024
BACKGROUND: Extended criteria donor (ECD) hearts available with donation after brain death (DBD) are underutilized for transplantation due to limitations of cold storage. OBJECTIVES: This study evaluated use of an extracorporeal perfusion system on donor h ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2024
OBJECTIVE: The effects of stroke and delirium on postdischarge cognition and patient-centered health outcomes after surgical aortic valve replacement (SAVR) are not well characterized. Here, we assess the impact of postoperative stroke and delirium on thes ...
Full textLink to itemCite
Journal ArticleArtif Organs · February 2024
BACKGROUND: As heart transplant guidelines evolve, the clinical indication for 73% of durable left ventricular assist device (LVAD) implants is now destination therapy. Although completely magnetically levitated LVAD devices have demonstrated improved dura ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2024
BACKGROUND: The long-term effectiveness of minithoracotomy over redo median sternotomy for reoperative mitral operation is not well described. Here we present long-term survival after reoperative mitral operation based on operative approach. METHODS: Adult ...
Full textLink to itemCite
Journal ArticlePLoS One · 2024
Preclinical disease models are important for the advancement of therapeutics towards human clinical trials. One of the difficult tasks of developing a well-characterized model is having a reliable modality with which to trend the progression of disease. Ac ...
Full textLink to itemCite
Journal ArticleJAMA · December 12, 2023
IMPORTANCE: Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagoni ...
Full textLink to itemCite
ConferenceJTCVS Tech · December 2023
OBJECTIVE: We developed a hybrid technique for repairing post-myocardial infarction (MI) ventricular septal defect (VSD) that combines infarct exclusion with patch and a nitinol-mesh septal occluder device (SOD) to provide a scaffold to support the damaged ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · November 2023
OBJECTIVES: To investigate whether recipient administration of thyroid hormone (liothyronine [T3]) is associated with reduced rates of primary graft dysfunction (PGD) after orthotopic heart transplantation. DESIGN: Retrospective cohort study. SETTING: Sing ...
Full textLink to itemCite
Journal ArticleTransplant Direct · November 2023
BACKGROUND: Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)-positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipients with ...
Full textLink to itemCite
Journal ArticleCirculation · October 24, 2023
BACKGROUND: Right ventricular failure (RVF) is a leading driver of morbidity and death after major cardiac surgery for advanced heart failure, including orthotopic heart transplantation and left ventricular assist device implantation. Inhaled pulmonary-sel ...
Full textOpen AccessLink to itemCite
Journal ArticleAm J Transplant · July 2023
Nontuberculous mycobacteria are emerging pathogens, yet data on the epidemiology and management of extrapulmonary nontuberculous mycobacteria infections in orthotopic heart transplantation (OHT) and ventricular assist device (VAD) recipients are scarce. We ...
Full textLink to itemCite
Journal ArticleN Engl J Med · June 8, 2023
BACKGROUND: Data showing the efficacy and safety of the transplantation of hearts obtained from donors after circulatory death as compared with hearts obtained from donors after brain death are limited. METHODS: We conducted a randomized, noninferiority tr ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Transl Res · June 2023
The porcine intra-abdominal heterotopic heart transplantation model allows for the assessment of immunologic effects on cardiac transplantation without relying on the allograft to maintain hemodynamic support for the animal. Historically, allograft functio ...
Full textLink to itemCite
Journal ArticleHum Gene Ther · April 2023
Transplantation, the gold standard intervention for organ failure, is a clinical field that is ripe for applications of gene therapy. One of the major challenges in applying gene therapy to this field is the need for a method that achieves consistent and r ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · February 2023
AIMS: We assessed the incidence, predictors and clinical correlates of de-novo aortic regurgitation (AR), which physiologically reduces left ventricular assist device (LVAD) effectiveness due to recirculation syndrome, in the MOMENTUM 3 trial portfolio of ...
Full textLink to itemCite
Journal ArticleJ Card Fail · January 2023
BACKGROUND: Primary graft dysfunction (PGD), the leading cause of early mortality after heart transplantation, is more common following donation after circulatory death (DCD) than donation after brain death (DBD). We conducted a single-center, retrospectiv ...
Full textLink to itemCite
Journal ArticleFront Cardiovasc Med · 2023
BACKGROUND: Reliable biomarkers for assessing the viability of the donor hearts undergoing ex vivo perfusion remain elusive. A unique feature of normothermic ex vivo perfusion on the TransMedics® Organ Care System (OCS™) is that the donor heart is maintain ...
Full textLink to itemCite
Chapter · January 1, 2023
Heart transplantation remains the most effective treatment for end-stage heart failure. Every transplant center has the prerogative to formulate its own organ acceptance criteria. This chapter focuses on the evaluation of the cardiac donor. It describes th ...
Full textCite
Journal ArticleJ Card Surg · December 2022
BACKGROUND: Heart donation after donor brain death from cardiac arrest despite successful resuscitation may be associated with worse recipient outcomes due to potential graft ischemia or underlying rhythmic/structural defects. However, selected grafts from ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2022
BACKGROUND: Concerns regarding long-term durability of surgical repair for functional mitral regurgitation are based on short-term data, with few comparisons of ischemic mitral regurgitation (IMR) versus nonischemic functional mitral regurgitation (NIFMR) ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · October 2022
We present our institution's protocol for evaluating and transplanting thoracic organs from COVID-19 positive donors and report the outcomes to date. Hearts from donors testing positive for COVID-19 on any test were eligible for transplantation at our inst ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · October 2022
OBJECTIVES: The prediction of right heart failure (RHF) after left ventricular assist device (LVAD) implantation remains a challenge. Recently, risk scores were derived from analysis of the European Registry for Patients with Mechanical Circulatory Support ...
Full textLink to itemCite
Journal ArticleJ Card Fail · September 2022
Heart transplantation remains the gold-standard therapy for end-stage heart failure; the expected median survival range is 12-13 years. More than 30,000 heart transplants have been performed globally in the past decade alone. With advances in medical and s ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · July 2022
BACKGROUND: In the MOMENTUM 3 (Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial, the HeartMate 3 (HM3) fully magnetically levitated left ventricular assist device (LVAD) de ...
Full textLink to itemCite
Journal ArticleCirculation · May 3, 2022
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failu ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 3, 2022
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failu ...
Full textLink to itemCite
Journal ArticleCirculation · May 3, 2022
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failu ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2, 2022
OBJECTIVES: Long-term left ventricular assist device (LVAD) support can cause accelerated progression of aortic insufficiency (AI). The MOMENTUM trial has led to increased use of the HeartMate 3 (HM3) LVAD, due to greater hemocompatibility. However, the di ...
Full textLink to itemCite
Journal ArticleASAIO J · May 1, 2022
Long-term continuous-flow left ventricular assist device (CFLVAD) therapy is limited by complications. Compared with stroke and renal dysfunction, post-CFLVAD bowel ischemia is poorly characterized. Adult patients who underwent first-time durable CFLVAD im ...
Full textLink to itemCite
Journal ArticleJ Card Fail · May 2022
BACKGROUND: The 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America (AHA/ACC/HFSA) Guideline for the Management of Heart Failure replaces the 2013 ACCF/AHA Guideline for the Management of Heart Failure and the 20 ...
Full textLink to itemCite
Journal ArticleJ Card Fail · May 2022
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failu ...
Full textLink to itemCite
Journal ArticleAm Heart J · March 2022
BACKGROUND: Post-operative AF (POAF) is the most common complication following cardiac surgery, occurring in 30% to 60% of patients undergoing bypass and/or valve surgery. POAF is associated with longer intensive care unit/hospital stays, increased healthc ...
Full textLink to itemCite
Journal ArticleJTCVS Open · March 2022
BACKGROUND: Patients with a left ventricular assist device with right ventricular failure are prioritized on the heart transplant waitlist; however, their post-transplant survival is less well characterized. We aimed to determine whether pretransplant righ ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · February 14, 2022
Cardiac transplantation is the gold standard treatment for end-stage heart failure. However, it remains limited by the number of available donor hearts and complications such as primary graft dysfunction and graft rejection. The recent clinical use of an e ...
Full textLink to itemCite
Journal ArticleJ Card Surg · February 2022
BACKGROUND: The durability of surgical repair for degenerative versus ischemic mitral regurgitation (MR) is thought to be markedly different. We, therefore, examined late outcomes and durability for mitral repair in a large cohort of patients receiving a s ...
Full textLink to itemCite
Journal ArticleASAIO J · February 1, 2022
We sought to characterize patients who underwent heart transplant (HTx) following destination therapy (DT) implant in the combined ENDURANCE/ENDURANCE Supplemental Trials (DT/DT2). A post hoc analysis of the DT/DT2 trials was performed. Baseline characteri ...
Full textLink to itemCite
Journal ArticleASAIO J · January 1, 2022
The study aim was to examine the impact time in therapeutic range (TTR, International Normalized Ratio [INR] 2.0-3.0) has on survival and adverse events in patients receiving the HeartWare HVAD System in the ENDURANCE and ENDURANCE Supplemental Trials. Eva ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2021
OBJECTIVES: To determine the frequency and risk factors for non-home discharge (NHD) and its association with clinical outcomes and quality of life (QOL) at 1Â year following cardiac surgery in patients with ischemic mitral regurgitation (IMR). METHODS: Dis ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · December 2021
PURPOSE: Clinical models to identify patients at high risk of primary graft dysfunction (PGD) after heart transplantation (HT) are limited, and the underlying pathophysiology of this common post-transplant complication remains poorly understood. We sought ...
Full textLink to itemCite
Journal ArticleASAIO J · October 1, 2021
Left ventricular assist devices (LVADs) improve quality of life (QoL) and functional capacity (FC) for patients with advanced heart failure. The association between adverse events (AEs) and changes in QoL and FC are unknown. Patients treated with the Heart ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · August 2021
BACKGROUND: Ventricular arrhythmias (VAs) and electrical storm (ES) are recognized complications following left ventricular assist device (LVAD) implantation; however, their association with long term-outcomes remains poorly understood. OBJECTIVE: The purp ...
Full textLink to itemCite
Journal ArticleJACC Case Rep · July 7, 2021
Many patients die while waiting for a heart transplant. Therefore, it is vital that all suitable organs are used for transplantation. We present a case of an allograft that was transplanted twice and outline considerations regarding tissue typing, the impa ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2021
BACKGROUND: In the era of antiretroviral therapy, HIV-positive patients have reduced mortality from HIV infection and increased morbidity from end-stage heart failure. The number of HIV-positive heart transplantation recipients remains scant. Long-term sur ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · May 2021
OBJECTIVE: Conventional ultrafiltration (CUF) during cardiopulmonary bypass (CPB) serves to hemoconcentrate blood volume to avoid allogeneic blood transfusions. Previous studies have determined CUF volumes as a continuous variable are associated with posto ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · April 2021
BACKGROUND: Heart transplantation is limited by the supply of donor organs. Previous studies have associated female donor to male recipient with decreased posttransplant survival. We wanted to evaluate whether this risk can be mitigated using higher donor ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · February 16, 2021
BACKGROUND: Whether to repair nonsevere tricuspid regurgitation (TR) during surgery for ischemic mitral valve regurgitation (IMR) remains uncertain. OBJECTIVES: The goal of this study was to investigate the incidence, predictors, and clinical significance ...
Full textOpen AccessLink to itemCite
Journal ArticleASAIO J · February 1, 2021
OptiVol (Medtronic PLC, Minneapolis, MN) is a diagnostic feature of some cardiac implantable electronic devices (CIEDs) based on changes in thoracic impedance (TI) over time. Changes in TI can predict heart failure (HF) hospitalizations and mortality in HF ...
Full textLink to itemCite
Journal ArticleSci Rep · January 18, 2021
Stroke is a devastating complication of left ventricular assist device (LVAD) therapy. Understanding the characteristics, risk factors and outcomes of strokes associated with the centrifugal flow LVADs is important to devise better strategies for managemen ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Comput Tomogr · 2021
BACKGROUND: Left ventricular assist devices (LVAD) are increasingly used for durable mechanical circulatory support in advanced heart failure. While LVAD therapy provides substantial improvement in mortality and quality of life, long-term therapy confers i ...
Full textLink to itemCite
Journal ArticleCardiovasc Pathol · 2021
Programmed death-ligand 1 (PD-L1), a transmembrane protein and member of the CD28 T cell family is associated with lymphocyte activation.1 PD-L1 expression is upregulated on activated antigen presenting cells such as monocytes, myeloid and dendritic cells. ...
Full textLink to itemCite
Chapter · January 1, 2021
An increasing number of high-risk patients are undergoing cardiac surgery. Despite this trend, advances in surgical techniques, myocardial preservation, anesthesia, and perioperative care have resulted in reduced morbidity and mortality. Positive outcomes ...
Full textCite
Journal ArticleJ Card Surg · November 2020
Implanting an inverted aortic valve prosthesis in the mitral position has shown to be a viable solution for a small mitral annulus. We describe a case of implanting an inverted in the mitral prosthesis in the aortic position in a patient with an excessivel ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · October 2020
Systemic right ventricle failure often develops in patients with dextro-transposition of the great arteries who have undergone atrial-level switch procedures. An adult with dextro-transposition of the great arteries with Mustard repair in childhood present ...
Full textLink to itemCite
Journal ArticleJ Card Surg · October 2020
BACKGROUND: Short duration, antimicrobial prophylaxis that includes antistaphylococcal activity is recommended at the time of left ventricular assist device (LVAD) implantation to reduce infection-related complications. There continues to be wide variabili ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · September 2020
OBJECTIVES: This study sought to determine the indications, characteristics, and outcomes of cardiovascular implantable electronic device (CIED) surgery in patients with LVAD. BACKGROUND: Many patients with a left ventricular assist device (LVAD) will requ ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2020
BACKGROUND: Patients with end-stage heart failure are increasingly being bridged to heart transplant (BTT) with mechanical circulatory support; however the association between a left ventricular assist device (LVAD) BTT strategy and posttransplant renal ou ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2020
BACKGROUND: Sensitized candidates with unacceptable antigens are a group that demands special attention in organ transplantation. Calculated panel reactive antigen (cPRA) is not used to modify allocation priorities in lung transplantation. The impact of cP ...
Full textLink to itemCite
Journal ArticleTranspl Int · August 2020
Acute kidney injury (AKI) and primary graft dysfunction (PGD) are serious complications after heart transplantation (HT). The relationship between AKI and PGD is poorly understood. We sought to examine the incidence of AKI and identify risk factors associa ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · July 2020
BACKGROUND: The HeartMate 3 (HM3) left ventricular assist device (LVAD) (Abbott, Inc, Chicago, Ill) is a fully magnetically levitated centrifugal implantable pump used to treat patients with chronic heart failure. The MOMENTUM (Multicenter Study of MagLev ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · July 2020
BACKGROUND: An early report of recipient heart transplantation outcomes under the new U.S. heart allocation system introduced in late 2018 found a lower post-transplant survival rate compared with that of the prior system. OBJECTIVES: The aim of this study ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · June 2020
OBJECTIVE: The Cardiothoracic Surgical Trials Network reported that left ventricular reverse remodeling at 2 years did not differ between patients with moderate ischemic mitral regurgitation randomized to coronary artery bypass grafting plus mitral valve r ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · June 2020
INTRODUCTION: Lead dysfunction can lead to serious consequences including failure to treat ventricular tachycardia or fibrillation (VT/VF). The incidence and mechanisms of lead dysfunction following left ventricular assist device (LVAD) implantation are no ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · June 2020
OBJECTIVES: The goal of this study was to assess the utility of transvenous lead extraction for cardiovascular implantable electronic device (CIED) infection in patients with a left ventricular assist device (LVAD). BACKGROUND: The use of transvenous lead ...
Full textLink to itemCite
Journal ArticleTransplantation · May 2020
BACKGROUND: Constrictive pericarditis is a rare, but increasingly recognized long-term postoperative complication of lung transplantation. Heightened clinical suspicion, improved diagnostic imaging, and effective surgical treatment of the disease have led ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2020
DCD heart donation has the potential to significantly increase the pool of available donor allografts in the US, by as much as 30%, and will lead to a substantial decrease in waiting list mortality. ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · May 2020
OBJECTIVES: This study sought to describe our institutional experience with establishing a neurocardiology service in an attempt to provide autonomic modulation as a treatment for ventricular arrhythmias (VAs). BACKGROUND: Treatment-refractory VAs are comm ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 2020
OBJECTIVES: We hypothesized that an increased duration of donor brain death may worsen survival following orthotopic heart transplantation. METHODS: The United Network for Organ Sharing Registry was queried for first-time, adult recipients of heart transpl ...
Full textLink to itemCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Cardiac gene therapy remains limited by inefficient transgene delivery with currently available methods (intravenous infusion, transcatheter coronary artery infusion, direct myocardial injection). We previously demonstrated in a porcine heterotopi ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Significant tricuspid regurgitation (TR) in patients undergoing durable left ventricular assist device (LVAD) implantation has been associated with increased incidence of right heart failure (RHF). There is great surgical practice variability rela ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Right heart failure (RHF) after LVAD implantation is associated with significant morbidity and mortality. Recently, the EUROMACS-RHF risk score was developed to predict postoperative RHF in this setting. In a single-center analysis, we assessed th ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: We previously reported that heart transplant (HTx) recipients with pre-formed, anti-HLA antibodies at low titer had one-year survival that was comparable to patients without any anti-HLA antibodies. As a result, we defined unacceptable HLA antigen ...
Full textCite
Journal ArticleCirc Heart Fail · April 2020
BACKGROUND: The NuPulseCV intravascular ventricular assist system (iVAS) provides extended duration ambulatory counterpulsation via a durable pump placed through the distal subclavian artery. METHODS: We performed a prospective, single-arm, multicenter, US ...
Full textLink to itemCite
Journal ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: We sought to examine the effects of early (non-GI) bleeding (EB) on length of stay and early mortality (3-months) in patients receiving the HeartwareTM HVADTM system for destination therapy. METHODS: HVAD patients enrolled in the ENDURANCE and END ...
Full textCite
Journal ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
OF OBJECTIVES: This is a single-arm, non-randomized study designed to assess the preliminary safety and clinical performance of a novel ambulatory counterpulsation device. The device is an intra-aortic, counterpulsation blood pump delivered via axillary ar ...
Full textCite
Journal ArticleASAIO J · March 2020
The need for biventricular support poses significant challenges for patients who require a mechanical bridge to transplantation. Recent improvements in ventricular assist device (VAD) technology has made possible the use of two centrifugal flow VADs as a t ...
Full textLink to itemCite
Journal ArticleHeart Lung Circ · March 2020
Left ventricular assist devices (LVADs) are used to support patients with advanced systolic heart failure (HF). These patients might develop LVAD dysfunction and consequent HF symptoms. Occasionally, outflow graft obstruction is responsible for LVAD dysfun ...
Full textLink to itemCite
Journal ArticleASAIO J · February 2020
Left ventricular assist devices are (LVAD) used for circulatory support in patients with end-stage heart failure. Hemolysis/pump dysfunction is a well-known complication of this therapy with various etiologic causes. A small proportion of these complicatio ...
Full textLink to itemCite
Journal ArticleJ Card Surg · February 2020
BACKGROUND AND AIM: Stroke remains a significant complication of left ventricular assist device (LVAD) therapy. We performed a single-center retrospective study evaluating patients undergoing first-time HeartWare HVAD (Medtronic Inc) or HeartMate 3 (Abbott ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · February 2020
OBJECTIVES: This study sought to determine the durability of tricuspid valve repair (TVr) performed concurrently with left ventricular assist device (LVAD) implantation and its association with the development of late right heart failure (RHF). BACKGROUND: ...
Full textOpen AccessLink to itemCite
Journal ArticleTranspl Int · November 2019
The association of donor and recipient age with survival following adult heart transplantation has not been well characterized. The purpose of this study was to examine the impact of the relationship between donor and recipient age on post-transplant survi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2019
BACKGROUND: Despite improvements in pump design and durability, left ventricular assist device patients still suffer from life-threatening complications such as pump thrombosis (PT) and infection, often necessitating device exchange. Surgical exchange from ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 3, 2019
Background The transplantation of hearts from traumatically brain-injured (TBI) donors has been associated with inferior long-term survival in single-center analyses. However, in a more recent analysis, death caused by cerebrovascular accident was associat ...
Full textLink to itemCite
Journal ArticleArtif Organs · July 2019
Intra-aortic balloon pump (IABP) is often used to support patients in decompensated heart failure. Placement of the IABP via the axillary artery facilitates long-term support with the device and may allow for the conversion of an acute heart failure (HF) p ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2019
BACKGROUND: Right heart failure occurs in 9% to 44% of left ventricular assist device (LVAD) implants, of which less than 10% require right ventricular assist device (RVAD) support either concurrently with the LVAD or staged, as a delayed procedure. We hav ...
Full textLink to itemCite
Journal ArticleAnesthesiology · June 2019
BACKGROUND: Cognitive decline after cardiac surgery occurs frequently and persists in a significant proportion of patients. Preclinical studies and human trials suggest that intravenous lidocaine may confer protection in the setting of neurologic injury. I ...
Full textOpen AccessLink to itemCite
Journal ArticleSci Rep · May 29, 2019
Clinically, both percutaneous and surgical approaches to deliver viral vectors to the heart either have resulted in therapeutically inadequate levels of transgene expression or have raised safety concerns associated with extra-cardiac delivery. Recent deve ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · May 21, 2019
BACKGROUND: The incidence of permanent pacemaker (PPM) implantation is higher following mitral valve surgery (MVS) with ablation for atrial fibrillation (AF) compared with MVS alone. OBJECTIVES: This study identified risk factors and outcomes associated wi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2019
BACKGROUND: Tricuspid valve regurgitation (TR) is a common finding immediately after cardiac transplantation. However, there is a scarcity of data regarding its implication if left untreated on long-term outcomes and the role of early surgical repair. METH ...
Full textLink to itemCite
Journal ArticleJ Eng Sci Med Diagn Ther · May 2019
Left ventricular assist devices (LVADs) are life-saving, surgically implanted mechanical heart pumps used to treat patients with advanced heart failure (HF). While life-saving, LVAD support is associated with a high incidence of complications, making early ...
Full textLink to itemCite
Journal ArticleN Engl J Med · April 25, 2019
BACKGROUND: In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device were less likely to have pump thrombosis or nondisabling stroke tha ...
Full textLink to itemCite
Journal ArticleJ Laparoendosc Adv Surg Tech A · April 2019
BACKGROUND: An increasing number of end-stage heart failure patients are supported with left ventricular assist device (LVAD) implantation and must be maintained on consistent anticoagulation. These patients are experiencing prolonged survival and, in some ...
Full textLink to itemCite
Journal ArticleJAMA · March 26, 2019
IMPORTANCE: Left ventricular assist device (LVAD) therapy improves myocardial function, but few patients recover sufficiently for explant, which has focused attention on stem cells to augment cardiac recovery. OBJECTIVE: To assess efficacy and adverse effe ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · March 1, 2019
Saphenous vein graft aneurysms after coronary artery bypass grafting (CABG) have been rarely reported. Their incidence and natural history are poorly defined. Herein, we present a patient who presented acutely with contained rupture of a large saphenous ve ...
Full textLink to itemCite
Journal ArticleHeart Rhythm · February 2019
BACKGROUND: Postoperative atrial fibrillation (POAF) frequently complicates cardiac surgery and is associated with worse outcomes. The cardiac autonomic nervous system is implicated in the pathogenesis of POAF. OBJECTIVE: The purpose of this study was to d ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · January 2019
BACKGROUND: Cardiac operation has been associated with increased risk of postoperative cognitive decline, as well as dementia risk in the general population. Few studies, however, have examined the impact of coronary revascularization or valve replacement ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · January 2019
OBJECTIVE: To use novel statistical methods for analyzing the effect of lesion set on (long-standing) persistent atrial fibrillation (AF) in the Cardiothoracic Surgical Trials Network trial of surgical ablation during mitral valve surgery (MVS). METHODS: T ...
Full textLink to itemCite
Journal ArticleCirculation · October 30, 2018
BACKGROUND: The MOMENTUM 3 trial compares the centrifugal HeartMate 3 (HM3) with the axial HeartMate II (HMII) continuous-flow left ventricular assist system in patients with advanced heart failure, irrespective of the intended goal of therapy. The trial's ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · October 2018
Invasive mold disease in thoracic organ transplant recipients is a well-recognized complication, but the long-term persistence of molds within the human body and evasion of host defenses has not been well-described. We present 2 cases of invasive mold dise ...
Full textLink to itemCite
Journal ArticleJ Oral Maxillofac Surg · September 2018
PURPOSE: An increasing number of patients with end-stage heart failure are supported with left ventricular assist device (LVAD) implantation and must be maintained on a consistent anticoagulation regimen. Pre-emptive extraction of carious teeth in these pa ...
Full textLink to itemCite
Journal ArticleJACC Heart Fail · September 2018
OBJECTIVES: The aim of this study was to prospectively evaluate the impact of blood pressure management on stroke rates in patients receiving the HeartWare HVAD System. BACKGROUND: The ENDURANCE trial demonstrated noninferiority of the HeartWare HVAD Syste ...
Full textLink to itemCite
Journal ArticleJ Clin Apher · August 2018
INTRODUCTION: Limited data are available describing indications for and outcomes of therapeutic plasma exchange (TPE) in cardiac transplantation. METHODS: In a retrospective study of patients who underwent cardiac transplantation at Duke University Medical ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Thromb Thrombolysis · August 2018
Bleeding frequently occurs in patients undergoing placement of a left ventricular assist device (LVAD). Clinical factors that have been identified as contributing to peri-procedural bleeding include LVAD implantation after an acute myocardial infarction an ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2018
Changes in heart transplantation (HT) donor and recipient demographics may influence the incidence of primary graft dysfunction (PGD). We conducted a retrospective study to evaluate PGD incidence, trends, and associated risk factors by analyzing consecutiv ...
Full textLink to itemCite
Journal ArticleJ Card Surg · June 2018
BACKGROUND: Patients with end-stage heart failure on left ventricular assist devices (LVADs) are predisposed to a high incidence of stroke. Preoperative factors associated with increased stroke risk are poorly understood. METHODS: We performed a single-cen ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · May 11, 2018
Mechanical circulatory support (MCS) has been introduced as a viable alternative to heart transplantation primarily through the use of intracorporeal ventricular assist devices (VADs) for support of the left ventricle. However, certain clinical scenarios w ...
Full textLink to itemCite
Journal ArticleMol Cell · May 3, 2018
Most G protein-coupled receptors (GPCRs) signal through both heterotrimeric G proteins and β-arrestins (βarr1 and βarr2). Although synthetic ligands can elicit biased signaling by G protein- vis-à -vis βarr-mediated transduction, endogenous mechanisms for b ...
Full textLink to itemCite
Journal ArticleAm Heart J · May 2018
BACKGROUND: Deaths from drug intoxication have increased in the United States but outcomes of recipients of orthotopic heart transplantation (OHT) from these donors are not well characterized. METHODS: We performed a retrospective analysis of the United Ne ...
Full textLink to itemCite
Journal ArticleN Engl J Med · April 12, 2018
BACKGROUND: In an early analysis of this trial, use of a magnetically levitated centrifugal continuous-flow circulatory pump was found to improve clinical outcomes, as compared with a mechanical-bearing axial continuous-flow pump, at 6 months in patients w ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 2018
OBJECTIVE: To analyze patient risk factors and processes of care associated with secondary surgical-site infection (SSI) after coronary artery bypass grafting (CABG). METHODS: Data were collected prospectively between February and October 2010 for consenti ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2018
BACKGROUND: Outcome of mitral valve replacement in extreme scenarios of small mitral annulus with the use of the Regent mechanical aortic valve is not well documented. METHODS: Records were examined in 31 consecutive patients who underwent mitral valve rep ...
Full textOpen AccessLink to itemCite
Journal ArticleAnesthesiology · April 2018
BACKGROUND: Amyloid deposition is a potential contributor to postoperative cognitive dysfunction. The authors hypothesized that 6-week global cortical amyloid burden, determined by F-florbetapir positron emission tomography, would be greater in those patie ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2018
BACKGROUND: The incidence of right ventricular dysfunction requiring right ventricular assist device after left ventricular assist device placement has been reported between 10% to 30%. The mortality rate is higher compared with patients who require left v ...
Full textLink to itemCite
Journal ArticleASAIO J · 2018
Frailty and heart failure share common pathways with symptoms that often coexist. Assessment of frailty may inform patient selection for left ventricular assist device (LVAD) therapy. Using Interagency Registry for Mechanically Assisted Circulatory Support ...
Full textLink to itemCite
Journal ArticleASAIO J · 2018
Left ventricular assist devices (LVADs) are being used widely to support patients with advanced systolic heart failure. Some of these patients will need more than one LVAD replacement due to pump thrombosis. The Heartmate III LVAD (Abbott Inc, Chicago, IL) ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · January 2018
BACKGROUND: Primary outcomes analysis of the Multicenter Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3 (MOMENTUM 3) trial short-term cohort demonstrated a higher survival rate free of debilitating stroke and reoperation to ...
Full textLink to itemCite
Journal ArticleJ Invasive Cardiol · January 2018
Axillary artery intraaortic balloon pump (IABP) placement enables those awaiting transplant to ambulate and get stronger, but motion increases risk of IABP migration. The management of a migrated pump in a 44-year-old man with heart failure is described. ...
Link to itemCite
Journal ArticleASAIO J · 2018
Use of durable, continuous-flow left ventricular assist devices (LVADs) has expanded rapidly, although data are limited regarding optimization strategies before LVAD implantation. We examined current use of intra-aortic balloon pumps (IABPs) before LVAD im ...
Full textLink to itemCite
Journal ArticleJ Cardiovasc Electrophysiol · December 2017
INTRODUCTION: Treatment refractory ventricular arrhythmias (VAs) are often driven and exacerbated by heightened sympathetic tone. We aim to conduct a systematic review and meta-analysis of published studies of a temporary percutaneous stellate ganglion blo ...
Full textLink to itemCite
Journal ArticleAnesth Analg · October 2017
BACKGROUND: Declining platelet counts may reveal platelet activation and aggregation in a postoperative prothrombotic state. Therefore, we hypothesized that nadir platelet counts after on-pump coronary artery bypass grafting (CABG) surgery are associated w ...
Full textOpen AccessLink to itemCite
Journal ArticleInteract Cardiovasc Thorac Surg · October 1, 2017
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: Is there a role for upper-extremity intra-aortic balloon pump counterpulsation (UE-IABP) in the treatment of end-stage heart failure? Altog ...
Full textLink to itemCite
ConferenceJACC Heart Fail · July 2017
OBJECTIVES: The authors sought to provide the pre-specified primary endpoint of the ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients) trial at 2 years. BACK ...
Full textLink to itemCite
Journal ArticleClin Transplant · July 2017
BACKGROUND: Orthotopic heart transplantation (OHT) is the gold-standard therapy for end-stage heart failure. An increasing deficit between suitable allograft availability and clinical demand for OHT exists. The role of donor diabetes mellitus (DM) on post- ...
Full textLink to itemCite
ConferenceClin Transplant · May 2017
BACKGROUND: Cardiac allografts are routinely evaluated by left ventricular ejection fraction (LVEF) before and after transplantation. However, myocardial deformation analyses with LV global longitudinal strain (GLS) are more sensitive for detecting impaire ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · April 1, 2017
BACKGROUND: Nontuberculous mycobacteria (NTM) commonly colonize municipal water supplies and cause healthcare-associated outbreaks. We investigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital. METHODS: Case patients had recen ...
Full textLink to itemCite
Journal ArticleN Engl J Med · February 2, 2017
BACKGROUND: Continuous-flow left ventricular assist systems increase the rate of survival among patients with advanced heart failure but are associated with the development of pump thrombosis. We investigated the effects of a new magnetically levitated cen ...
Full textLink to itemCite
Journal ArticleN Engl J Med · February 2, 2017
BACKGROUND: Mechanical circulatory support with a left ventricular assist device (LVAD) is an established treatment for patients with advanced heart failure. We compared a newer LVAD design (a small intrapericardial centrifugal-flow device) against existin ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · February 2017
BACKGROUND: Pre-transplant amiodarone use has been postulated as a risk factor for morbidity and mortality after orthotopic heart transplantation (OHT). We assessed pre-OHT amiodarone use and tested the hypothesis that it is associated with impaired post-O ...
Full textLink to itemCite
Journal ArticleASAIO J · 2017
Left ventricular assist device (LVAD) therapy unloads the failing heart but exposes the human body to unique pathophysiologic demands such as continuous blood flow and complete univentricular support, which are associated with increased risk of adverse cli ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · 2017
We evaluated the feasibility, tolerability, and efficacy of a strategy for transaxillary artery intra-aortic balloon pump placement for extended mechanical circulatory support of patients with postcardiotomy shock as a bridge to recovery. Patients requirin ...
Full textLink to itemCite
Journal ArticleClin Transplant · December 2016
BACKGROUND: Acute hypothyroidism after brain death results in hemodynamic impairments that limit availability of donor hearts. Thyroid hormone infusions can halt that process and lead to increased utilization of donor organs, but prolonged use of thyroid r ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2016
Improved quality of life for patients after left ventricular assist device (LVAD) implantation can be greatly limited by peripheral vascular disease even if heart failure symptoms are resolved by LVAD support. We present a case of concomitant thoracic aort ...
Full textLink to itemCite
Journal ArticleCatheter Cardiovasc Interv · September 2016
Cardiogenic shock is a common clinical condition with high in-hospital mortality. Early application of appropriate interventions for cardiogenic shock-including medical therapies, revascularization, temporary hemodynamic support devices, and durable mechan ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 1, 2016
Within the last decade, advancements in left ventricular assist device therapy have allowed patients with end-stage heart failure (HF) to live longer and with better quality of life. Like other life-saving interventions, however, there remains the risk of ...
Full textLink to itemCite
Journal ArticleDig Dis Sci · June 2016
INTRODUCTION: Left ventricular assist devices (LVADs) are increasingly common in patients with advanced heart failure. GI bleeding (GIB) occurs in 20-30Â % of these patients and can arise anywhere in the GI tract. Given the high rates of GIB in this populat ...
Full textLink to itemCite
Journal ArticleN Engl J Med · May 19, 2016
BACKGROUND: In a trial comparing coronary-artery bypass grafting (CABG) alone with CABG plus mitral-valve repair in patients with moderate ischemic mitral regurgitation, we found no significant difference in the left ventricular end-systolic volume index ( ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · May 2016
BACKGROUND: Heart transplantation is increasing in patients with adult congenital heart disease (ACHD). In this population, the association of pulmonary hypertension (PH) with post-transplant outcomes is not well-defined. METHODS: Using data from the Unite ...
Full textLink to itemCite
Journal ArticleTex Heart Inst J · April 2016
A 69-year-old man presented with a progressively enlarging pulsatile mass in the left side of his chest. Because of a history of an ischemic cardiomyopathy, he had been randomized in 2003 to undergo coronary artery bypass grafting with a Dor procedure, as ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · March 2016
BACKGROUND: With increasing age of patients with heart failure, it is important to understand the potential role for orthotopic heart transplant (OHT) in elderly patients. We examined recipient and donor characteristics and long-term outcomes of older reci ...
Full textLink to itemCite
Journal ArticleJ Card Fail · March 2016
BACKGROUND: Patients with advanced heart failure may continue for prolonged times with persistent hemodynamic abnormalities; intermediate- and long-term outcomes of these patients are unknown. METHODS AND RESULTS: We used ESCAPE (Evaluation Study of Conges ...
Full textLink to itemCite
Journal ArticleJ Mol Cell Cardiol · March 2016
Atrial tissue gene expression profiling may help to determine how differentially expressed genes in the human atrium before cardiopulmonary bypass (CPB) are related to subsequent biologic pathway activation patterns, and whether specific expression profile ...
Full textLink to itemCite
Journal ArticleJ Card Fail · February 2016
BACKGROUND: Although primary graft dysfunction (PGD) is a leading cause of mortality and morbidity early post-heart transplant, relatively little is known regarding mechanisms involved in PGD development. METHODS AND RESULTS: We examined the relationship b ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2016
A centrifugal left ventricular assist device can be replaced through a left anterior minithoracotomy with retention of the old outflow graft and apical sewing ring. Technical considerations encountered during five successful replacements are described. ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · January 26, 2016
BACKGROUND: Heart failure (HF) is characterized by perturbations in energy homeostasis and metabolism. The reversibility and prognostic value of circulating markers associated with these changes remain unclear. OBJECTIVES: This study sought to describe the ...
Full textLink to itemCite
Journal ArticleASAIO J · 2016
Advances in technology for the delivery of venoarterial extracorporeal membrane oxygenation (VA-ECMO) have allowed for its expanded utilization in the treatment of patients with advanced cardiogenic shock, particularly through the use of peripheral cannula ...
Full textLink to itemCite
Journal ArticleASAIO J · 2016
The proportion of heart transplant recipients bridged with durable, intracorporeal left ventricular assist devices (dLVADs) has dramatically increased; however, concern exists regarding obligate repeat sternotomy, increased bleeding risk because of anticoa ...
Full textLink to itemCite
Journal ArticleASAIO J · 2016
The most promising alternatives to heart transplantation are left ventricular assist devices and artificial hearts; however, their use has been limited by thrombotic complications. To reduce these, sintered titanium (Ti) surfaces were developed, but thromb ...
Full textLink to itemCite
Journal ArticleASAIO J · 2016
Left heart disease (LHD) represents the most common cause of pulmonary hypertension (PH), and is associated with worse prognosis compared with LHD without PH. In addition, PH due to LHD may prevent patients from receiving heart transplantation, because of ...
Full textLink to itemCite
Journal ArticleTransfusion · December 2015
BACKGROUND: Although numerous studies have demonstrated the feasibility of cardiac surgery for blood refusal patients, few studies match to controls, and fewer examine cost. This historical cohort study aims to compare costs and outcomes after cardiac surg ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · December 2015
BACKGROUND: Right ventricular failure (RVF) increases morbidity and mortality. The RECOVER RIGHT study evaluated the safety and efficacy of a novel percutaneous right ventricular assist device, the Impella RP (Abiomed, Danvers, MA), in a prospective, multi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2015
Carcinoid tumors rarely metastasize to the heart, and previous reports involved the myocardium only. We present a case of carcinoid tumor metastatic to the right ventricle (RV) and tricuspid valve. Preoperative cardiac magnetic resonance imaging (CMR) show ...
Full textLink to itemCite
Journal ArticleStem Cells Dev · November 15, 2015
Cardiovascular disease is the leading cause of death in the United States. Heart failure is a common, costly, and potentially fatal condition that is inadequately managed by pharmaceuticals. Cardiac repair therapies are promising alternative options. A pot ...
Full textLink to itemCite
Journal ArticleEur Heart J · October 21, 2015
AIMS: The management and outcomes of patients with functional moderate/severe mitral regurgitation and severe left ventricular (LV) systolic dysfunction are not well defined. We sought to determine the characteristics, management strategies, and outcomes o ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · October 20, 2015
BACKGROUND: Data for left ventricular assist devices (LVADs) in patients with noninotrope-dependent heart failure (HF) are limited. OBJECTIVES: The goal of this study was to evaluate HeartMate II (HMII) LVAD support versus optimal medical management (OMM) ...
Full textLink to itemCite
Journal ArticleKidney Int · October 2015
Acute kidney injury (AKI) is a common, serious complication of cardiac surgery. Since prior studies have supported a genetic basis for postoperative AKI, we conducted a genome-wide association study (GWAS) for AKI following coronary bypass graft (CABG) sur ...
Full textOpen AccessLink to itemCite
Journal ArticleAm Heart J · September 2015
BACKGROUND: Postoperative atrial fibrillation (AF) is a potentially life-threatening complication after coronary artery bypass graft (CABG) surgery. Genetic predisposition may predict risk for developing postoperative AF. METHODS: Study subjects underwent ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · August 15, 2015
Alternatives have emerged for patients ineligible for cardiac transplantation under standard criteria. The purpose of our study was to compare outcomes in patients ineligible for cardiac transplantation under standard criteria, treated either with extended ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2015
BACKGROUND: The efficacy of conventional median sternotomy versus a right minithoracotomy (RT) approach to mitral valve surgery was evaluated in a single high-volume institution. METHODS: A retrospective analysis of a single institution's experience was pe ...
Full textOpen AccessLink to itemCite
Journal ArticleA A Case Rep · May 15, 2015
We present the case of a 53-year-old female Jehovah's Witness with nonischemic cardiomyopathy who successfully underwent a bloodless heart transplantation using fibrinogen concentrate (RiaSTAP; CSL Behring, King of Prussia, PA) and other blood-conservation ...
Full textLink to itemCite
Journal ArticleEur J Heart Fail · April 2015
AIMS: We sought to evaluate associations between baseline sphericity index (SI) and clinical outcome, and changes in SI after coronary artery bypass graft (CABG) surgery with or without surgical ventricular reconstruction (SVR) in ischaemic cardiomyopathy ...
Full textLink to itemCite
Journal ArticleOperative Techniques in Thoracic and Cardiovascular Surgery · February 3, 2015
A total of 2 small, electrical, centrifugal pumps can be implanted as a total artificial heart replacement. This type of mechanical support may be advantageous in the setting of severe biventricular failure when cannulation of the native ventricles is comp ...
Full textCite
ConferenceJ Crit Care · December 2014
OBJECTIVE: Although hemodynamic monitoring is often performed after coronary artery bypass grafting (CABG), the role of monitoring postoperative central venous pressure (CVP) measurement as a predictor of clinical outcomes is unknown. As such, this study t ...
Full textLink to itemCite
Journal ArticleAnn Cardiothorac Surg · November 2014
The past five years have seen remarkable growth in the use of durable, continuous flow left ventricular assist devices (LVAD) with associated improvements in mortality, quality of life, functionality and end-organ function. To sustain the growth of this im ...
Full textOpen AccessLink to itemCite
OtherCirc Cardiovasc Genet · October 2014
BACKGROUND: We hypothesized that genetic variations in the adrenergic signaling pathway and cytochrome P450 2D6 enzyme are associated with new-onset atrial fibrillation (AF) in patients who underwent coronary artery bypass grafting and were treated with pe ...
Full textLink to itemCite
Journal ArticlePacing Clin Electrophysiol · October 2014
BACKGROUND: Preprocedural multidetector computed tomography (MDCT) may identify patients at risk for mechanical complications during lead extraction. METHODS: To describe the use and feasibility of computed tomography scanning for preprocedural planning of ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · October 1, 2014
There are limited data integrating findings on right-sided cardiac catheterization and cardiopulmonary exercise testing in ambulatory patients with heart failure. In this study, 187 outpatients with HF referred to the Duke Medical Center for consideration ...
Full textLink to itemCite
Journal ArticleCirculation · September 9, 2014
BACKGROUND: Cardiac valve procedures are commonly performed concurrently during implantation of left ventricular assist devices, but the added procedural risk has not been studied in detail. METHODS AND RESULTS: Data from patients receiving the HeartWare V ...
Full textLink to itemCite
ConferenceJ Heart Lung Transplant · September 2014
BACKGROUND: Aortic insufficiency (AI) in patients supported with continuous-flow left ventricular assist devices (CF-LVAD) results in regurgitant volume returning from the aorta to the left ventricle, increased LVAD pump volume and reduced systemic cardiac ...
Full textLink to itemCite
Journal ArticleJ Vis Exp · June 11, 2014
Since its introduction in the late 19(th) century, the Langendorff isolated heart perfusion apparatus, and the subsequent development of the working heart model, have been invaluable tools for studying cardiovascular function and disease(1-15). Although th ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · June 3, 2014
BACKGROUND: Allogeneic mesenchymal precursor cells (MPCs) injected during left ventricular assist device (LVAD) implantation may contribute to myocardial recovery. This trial explores the safety and efficacy of this strategy. METHODS AND RESULTS: In this m ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 15, 2014
OBJECTIVES: This study sought to examine trends in mortality, readmission, and costs among Medicare beneficiaries receiving ventricular assist devices (VADs) and associations between hospital-level procedure volume and outcomes. BACKGROUND: VADs are an opt ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · March 11, 2014
OBJECTIVES: This study sought to determine the pre-operative risk factors related to late bleeding, stroke, and pump thrombosis in patients with HeartMate II (HMII) left ventricular assist devices (LVADs) (Thoratec Corporation, Pleasanton, California) that ...
Full textLink to itemCite
Journal ArticleJ Card Fail · February 2014
BACKGROUND: Despite chronic systemic anticoagulation, advanced heart failure patients treated with a continuous-flow left ventricular assist device (LVAD) remain at risk for pump thrombosis. Pump thrombosis may initially be suspected in the setting of clin ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2014
BACKGROUND: Preexisting valve pathology is common in patients with end-stage heart failure undergoing left ventricular assist device (LVAD) placement. The indications and subsequent benefits of performing valvular procedures in these patients are unclear. ...
Full textLink to itemCite
Journal ArticleN Engl J Med · January 2, 2014
BACKGROUND: We observed an apparent increase in the rate of device thrombosis among patients who received the HeartMate II left ventricular assist device, as compared with preapproval clinical-trial results and initial experience. We investigated the occur ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · January 2014
BACKGROUND: Pump thrombosis remains an uncommon but potentially catastrophic complication of durable continuous-flow left ventricular assist devices (LVAD). A perceived increase in the incidence of pump thrombosis in the HeartMate II (HMII) LVAD (Thoratec, ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · January 2014
Patients with advanced HF and coexisting VHD who undergo LVAD implantation constitute a growing population and pose unique challenges in clinical and surgical management. Contemporary continuous-flow LVADs alter blood flow dynamics and cardiovascular physi ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
The molecular differences between ischemic (IF) and non-ischemic (NIF) heart failure are poorly defined. A better understanding of the molecular differences between these two heart failure etiologies may lead to the development of more effective heart fail ...
Full textOpen AccessLink to itemCite
Journal ArticleStroke · December 2013
BACKGROUND AND PURPOSE: Neurocognitive decline occurs frequently after cardiac surgery and persists in a significant number of patients. Magnesium is thought to provide neuroprotection by preservation of cellular energy metabolism, blockade of the N-methyl ...
Full textLink to itemCite
Journal ArticleJ Heart Valve Dis · November 2013
BACKGROUND AND AIM OF THE STUDY: Detailed analyses of risk-adjusted outcomes after mitral valve surgery have documented significant survival decrements with tissue valves at any age. Several recent studies of prosthetic aortic valve replacement (AVR) also ...
Link to itemCite
Journal ArticleCirc Heart Fail · November 2013
BACKGROUND: Extended criteria cardiac transplant (ECCT) programs expand the transplant pool by matching donors and recipients typically excluded from the transplant process because of age or comorbidity. There is a paucity of data examining long-term outco ...
Full textLink to itemCite
Journal ArticleSurgery · August 2013
BACKGROUND: Cardiac transplantation is an effective therapy for patients with end-stage heart failure, but it is still hindered by the lack of donor organs. A history of donor cardiac arrest raises trepidation regarding the possibility of poor post-transpl ...
Full textLink to itemCite
Journal ArticleTransl Res · April 2013
Ischemic cardiovascular disease remains the leading cause of death worldwide. Despite advances in the medical management of atherosclerosis over the past several decades, many patients require arterial revascularization to reduce mortality and alleviate is ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 2013
OBJECTIVE: Coronary artery bypass grafting with multiple internal thoracic artery grafts is currently controversial. This study assessed single institutional outcomes with multiple internal thoracic artery grafting for guidance with future clinical decisio ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2013
BACKGROUND: Although continuous-flow left ventricular assist devices (LVAD) are durable and reliable, device replacement will be inevitable in some patients. We evaluated the incidence and outcomes of pump replacement procedures with the HeartMate II (Thor ...
Full textLink to itemCite
Journal ArticleHeart Lung Vessel · 2013
INTRODUCTION: Ischemic mitral regurgitation can be defined as moderate to severe mitral leak precipitated by acute myocardial infarction. Valve repair is now the procedure of choice, but some cases can pose difficult anatomy. This review will illustrate cu ...
Link to itemCite
Journal ArticleInnovations (Phila) · 2013
OBJECTIVE: Compared with median sternotomy, a right thoracotomy (RT) approach to mitral surgery is associated with decreased postoperative acute renal failure. Therefore, we examined propensity-matched patients with chronic renal impairment to compare outc ...
Full textLink to itemCite
Journal ArticleASAIO J · 2013
A 69-year-old man with advanced heart failure treated with a continuous-flow left ventricular assist device presented for evaluation of dark urine and severe dysphagia. Because of evidence of ongoing intravascular hemolysis with device dysfunction, there w ...
Full textLink to itemCite
Journal ArticleASAIO J · 2013
Primary adrenal insufficiency or Addison's disease is a rare disorder often difficult to diagnose on presentation by the nature of its associated nonspecific symptoms, such as nausea or weakness. Cardiovascular complications of the condition are usually li ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · 2013
There are a myriad of surgical therapies for patients with end-stage congestive heart failure. Coronary revascularization and mitral valve repair have clear clinical benefits in appropriately selected patients. Further investigation is required before the ...
Full textLink to itemCite
Journal ArticleHum Gene Ther · October 2012
Adeno-associated virus type 3b (AAV3b) has been largely ignored by gene therapists because of the inability of vectors based on this serotype to transduce target tissues efficiently. Here we describe a phenomenon unique to AAV3b in that vectors based on th ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2012
BACKGROUND: In high-risk cardiac procedures, dynamic analysis of right ventricular (RV) performance is desirable, but the geometric complexity of the RV limits the applicability of current two-dimensional echocardiographic imaging techniques. This study ai ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · July 2012
PURPOSE: A universal loss of von Willebrand factor (vWF) high-molecular-weight multimers (HMWM) has been demonstrated in continuous-flow left ventricular assist device (HeartMate II) recipients. However, no reliable clinical or laboratory predictors for an ...
Full textLink to itemCite
Journal ArticleHum Gene Ther · June 2012
Successful amelioration of cardiac dysfunction and heart failure through gene therapy approaches will require a transgene effective at attenuating myocardial injury, and subsequent remodeling, using an efficient and safe delivery vehicle. Our laboratory ha ...
Full textLink to itemCite
Journal ArticleTranspl Infect Dis · June 2012
Transmission of pathogens from donor to recipient is a potential complication of organ transplantation. Herein, we describe the clinical course and outcomes of 4 transplant recipients who received tissues from a donor with multi-organ infection with Klebsi ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2012
Cardiac haemangioma is an extremely rare, benign vascular tumour. A 42-year-old female patient who was previously very active presented with complaints of exertional chest pain as well as lower extremity oedema. Computed tomography and magnetic resonance i ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · March 1, 2012
BACKGROUND: The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant improvements in outcomes in continuous-flow left ventricular assist devices compared with patients implanted with the pulsatile-flow HeartMate XVE. The primary hypo ...
Full textLink to itemCite
Journal ArticleClin Transplant · 2012
Caregivers for patients undergoing solid organ transplantation play an essential role in the process of transplantation. However, little is known about stress and coping among these caregivers. Six hundred and twenty-one primary caregivers of potential can ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · November 2011
OBJECTIVE: Postoperative sternal wound complications are a significant problem in high-risk patients. In addition to closure with conventional wires, several systems involving rigid fixation with metal plates are currently available. The rapid sternal clos ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2011
BACKGROUND: Almost 50% of patients referred for implantable left ventricular assist device (LVAD) have significant tricuspid regurgitation (TR). Preoperative TR is associated with negative outcomes but the clinical benefit of concomitant tricuspid valve pr ...
Full textLink to itemCite
Journal ArticleHeart Fail Clin · October 2011
Recent advances in mechanically assisted circulation, including refinement of patient selection criteria and enhancements in device design, have been associated with improvements in survival, functionality and quality of life as well as reductions in adver ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · July 2011
In every common mitral pathology studied to date, repairing the patient's own diseased valve to adequate function has yielded superior long-term results as compared with prosthetic valve replacement with either tissue or mechanical devices. Thus, increasin ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · July 2011
An unusual problem associated with the use of left ventricular assist devices (LVADs) relates to malposition of the apical inflow cannula. From 2005 to 2010, we implanted 154 continuous-flow HeartMate II (Thoratec, Pleasanton, CA) LVADs at our institution. ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2011
BACKGROUND: Inclusion of a measure of left ventricular diastolic dysfunction (LVDD) may improve risk prediction after cardiac surgery. Current LVDD grading guidelines rely on echocardiographic variables that are not always available or aligned to allow gra ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2011
BACKGROUND: The progression of tricuspid valve regurgitation (TR) and the impact of preoperative TR on postoperative outcomes in patients having left ventricular assist device (LVAD) implantation has not been studied. METHODS: One hundred seventy-six conse ...
Full textLink to itemCite
Journal ArticleBiomaterials · January 2011
Implantable and extracorporeal cardiovascular devices are commonly made from titanium (Ti) (e.g. Ti-coated Nitinol stents and mechanical circulatory assist devices). Endothelializing the blood-contacting Ti surfaces of these devices would provide them with ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2010
OBJECTIVE: Achieving transmural tissue ablation might be necessary for successful treatment of atrial fibrillation. The purpose of this study was to evaluate the reproducibility of transmural left atrial ablation using a high-intensity focused ultrasound e ...
Full textLink to itemCite
Journal ArticleTransfusion · November 2010
BACKGROUND: The relationship between duration of platelet (PLT) storage, currently limited to 5days, and surgical outcomes has not been established. We tested the hypothesis that PLT storage age was associated with adverse outcomes. STUDY DESIGN AND METHOD ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2010
BACKGROUND: Previous studies suggest that mitral valve replacement is comparable to repair in the elderly, and a national trend exists toward tissue valves. However, few direct comparison data are available, and this study evaluated the effects of patient ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2010
BACKGROUND: Bleeding is a major cause of morbidity in recipients of continuous-flow left ventricular assist devices (CF-LVAD). A better understanding of the impact of CF-LVAD support on the hemostatic profile is necessary to establish better strategies for ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · July 2010
OBJECTIVE: Although left ventricular assist devices (LVADs) are associated with excellent outcomes in patients with end-stage heart failure, there are conflicting reports on posttransplant survival in these patients. Furthermore, prior studies with pulsati ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2010
PURPOSE: Midline sternotomy remains the preferred technique for access in cardiac surgery. Application of steel wires has been the preferred method of closure. Because of associated complications, such as superficial and deep infections, as well as bony no ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2010
OBJECTIVE: The aim of this study was to evaluate the incidence, risk factors, and effect on outcomes of right ventricular failure in a large population of patients implanted with continuous-flow left ventricular assist devices. METHODS: Patients (n = 484) ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 27, 2010
OBJECTIVES: This study sought to assess the impact of continuous flow left ventricular assist devices (LVADs) on functional capacity and heart failure-related quality of life. BACKGROUND: Newer continuous-flow LVAD are smaller and quieter than pulsatile-fl ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2010
BACKGROUND: End-stage heart failure is a growing problem associated with a high mortality using conventional medical care. Although cardiac transplantation is an excellent treatment option, it is a limited resource and most patients are ineligible for card ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2010
BACKGROUND: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major postoperative complication. Although some early recovery is common, its effect on long-term outcomes is unclear. We tested the hypothesis that early renal recovery after CSA-AK ...
Full textLink to itemCite
Journal ArticleASAIO J · 2010
A higher rate of nonsurgical bleeding has been observed in nonpulsatile left ventricular assist device (LVAD) recipients. von Willebrand factor (vWF) profiles were compared for nonpulsatile and pulsatile LVAD recipients to explore mechanisms that may contr ...
Full textLink to itemCite
Journal ArticleAnesth Analg · January 1, 2010
BACKGROUND: Heparin-induced thrombocytopenia (HIT) complicates the management of patients presenting for cardiac surgery, because high-dose heparin anticoagulation for cardiopulmonary bypass is contraindicated in these patients. Alternative anticoagulants ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · January 2010
OBJECTIVE: : The relative outcomes of sternotomy versus thoracotomy for tricuspid valve operation were examined over a 22-year period. METHODS: : Three hundred four consecutive patients undergoing tricuspid valve operation using right minithoracotomy (THOR ...
Full textLink to itemCite
Journal ArticleCirculation · December 8, 2009
BACKGROUND: The effects of continuous blood flow and reduced pulsatility on major organ function have not been studied in detail. METHODS AND RESULTS: We evaluated renal (creatinine and blood urea nitrogen) and hepatic (aspartate transaminase, alanine tran ...
Full textLink to itemCite
Journal ArticleN Engl J Med · December 3, 2009
BACKGROUND: Patients with advanced heart failure have improved survival rates and quality of life when treated with implanted pulsatile-flow left ventricular assist devices as compared with medical therapy. New continuous-flow devices are smaller and may b ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2009
BACKGROUND: Recent advances in surgical technique allow repair of most mitral valves with degenerative disease. However, few long-term data exist to support the superiority of repair versus prosthetic valve replacement, and repair could be limited by late ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2009
BACKGROUND: Bridge to heart transplantation with a left ventricular assist device (LVAD) can be a promising therapy for patients who are not effectively stabilized with conservative measures. However, referral for LVAD therapy may be limited secondary to r ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2009
BACKGROUND: Undersized ring annuloplasty and surgical revascularization are commonly used to correct ischemic mitral regurgitation (MR), but published series have failed to demonstrate a benefit compared with revascularization alone. We hypothesized that s ...
Full textLink to itemCite
Journal ArticleCirculation · September 15, 2009
BACKGROUND: The objective of this study was to determine the impact of concurrent cardiac procedures (CCP) on patient outcomes after HeartMate II (HMII) left ventricular assist device implantation. METHODS AND RESULTS: Two hundred eighty-one patients under ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · September 2009
A 24-year-old man with Marfan syndrome underwent mitral valve repair for prolapse at age 13. He sustained an acute type A aortic dissection at age 20 and underwent aortic root/ascending aortic replacement with a mechanical valved conduit. He initially did ...
Full textLink to itemCite
Journal ArticleSurg Clin North Am · August 2009
Patients with heart failure represent a significantly ill cohort, and the survival of the most advanced heart failure patients is dismal with medical management alone. This cohort of advanced heart-failure patients benefits from several surgical treatments ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2009
BACKGROUND: The development of laser-assisted extraction techniques for chronically implanted pacemaker and defibrillator leads has reduced the need for open surgical removal. Reports of the mortality from laser-assisted extraction range from 1.9% to 3.4%. ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2009
OBJECTIVE: Right ventricular hypertrophy and subsequent dysfunction is common in patients with congenital heart defects, but the molecular mechanisms underlying change from adaptive hypertrophy to dysfunction remain elusive. We used the novel technique of ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · May 2009
BACKGROUND: The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) is an NIH-sponsored registry of US FDA-approved mechanical circulatory support devices (MCSDs) used for destination therapy, bridge to transplantation (BTT), or ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2009
Given the aging population, use of an apicoaortic conduit serves as an alternative method to treat severe aortic stenosis, especially in patients with a heavily calcified ascending aorta or prior cardiac surgery. Although an apicoaortic conduit fractionate ...
Full textLink to itemCite
Journal ArticleBlood Purif · 2009
BACKGROUND/AIMS: Acute renal failure is associated with a high risk of mortality when it complicates coronary artery bypass graft (CABG) surgery. We examined a large nationwide database from 1988 to 2003 and hypothesized that mortality in CABG-associated a ...
Full textLink to itemCite
Journal ArticleRen Fail · 2009
Acute renal failure (ARF) is common after cardiac surgery and more frequent after complex cardiac surgery. While the incidence of ARF is increasing after coronary artery bypass graft (CABG) surgery, trends in other forms of cardiac surgery remain unclear. ...
Full textLink to itemCite
Journal ArticleCirc Heart Fail · January 2009
BACKGROUND: More than 400 patients with end-stage heart failure underwent left ventricular assist device (LVAD) implantation of LVAD as destination therapy (DT) after the US Food and Drug Administration approval of DT in 2002. Because most of these patient ...
Full textLink to itemCite
Journal ArticleHSR Proc Intensive Care Cardiovasc Anesth · 2009
INTRODUCTION: New evidence of potential risks of aprotinin in 2006 generated public concern about a previously approved drug that was routinely used. In response, we assembled a team of experts within the institution to form guidelines for the appropriate ...
Link to itemCite
Journal ArticleJAMA · November 26, 2008
CONTEXT: In 2003, Medicare expanded coverage of ventricular assist devices as destination, or permanent, therapy for end-stage heart failure. Little is known about the long-term outcomes and costs associated with these devices. OBJECTIVE: To examine the ac ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 2008
BACKGROUND: We have previously shown that extended criteria heart transplant recipient mortality is higher than standard list mortality, but this is not associated with an increased incidence of either primary graft dysfunction or acute rejection. We hypot ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2008
BACKGROUND: Ischemic mitral regurgitation (IMR) has an adverse prognosis, but survival characteristics and management are controversial. This study reviewed a 20-year series of IMR patients managed with multiple approaches to assess and refine surgical str ...
Full textLink to itemCite
Journal ArticleN Engl J Med · February 21, 2008
BACKGROUND: Aprotinin has recently been associated with adverse outcomes in patients undergoing cardiac surgery. We reviewed our experience with this agent in patients undergoing cardiac surgery at Duke University Medical Center. METHODS: We retrieved data ...
Full textLink to itemCite
Journal ArticleCirculation · November 27, 2007
BACKGROUND: Downregulation of beta-adrenergic receptors (betaARs) under conditions of heart failure requires receptor targeting of phosphoinositide 3-kinase (PI3K)-gamma and redistribution of betaARs into endosomal compartments. Because support with a left ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · November 15, 2007
Differences in the clinical and angiographic factors associated with short- and long-term outcomes in patients undergoing coronary artery bypass grafting (CABG) are less known. Accordingly, differences were examined in clinical and angiographic correlates ...
Full textLink to itemCite
Journal ArticleAnesthesiology · November 2007
BACKGROUND: Patients undergoing coronary artery bypass graft (CABG) surgery frequently develop wall motion abnormalities diagnosed by intraoperative transesophageal echocardiography. However, the relation between deterioration in wall motion and postoperat ...
Full textLink to itemCite
Journal ArticleCrit Care Med · October 2007
OBJECTIVE: Acute renal failure remains a major complication of coronary artery bypass graft surgery that is strongly associated with in-hospital mortality. Based on similar observations in other clinical settings, we tested the hypothesis that the diagnosi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2007
BACKGROUND: The presence of heparin-induced thrombocytopenia (HIT) increases the risk for thromboembolic events in ventricular assist device (VAD) patients undergoing transplantation. However, cardiopulmonary bypass with alternative anticoagulants is often ...
Full textLink to itemCite
Journal ArticleCirculation · July 31, 2007
BACKGROUND: The landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial first demonstrated that implantation of left ventricular assist devices (LVADs) as destination therapy (DT) can provide su ...
Full textLink to itemCite
Journal ArticleCirculation · July 4, 2006
BACKGROUND: The inflammatory response triggered by cardiac surgery with cardiopulmonary bypass (CPB) is a primary mechanism in the pathogenesis of postoperative myocardial infarction (PMI), a multifactorial disorder with significant inter-patient variabili ...
Full textLink to itemCite
Journal ArticleCirculation · July 4, 2006
BACKGROUND: Clinical success with modern heart transplantation (HT) has led to the development of an alternate list (AL) HT strategy, matching marginal cardiac allografts with recipients who do not meet standard criteria for HT. Marginal allografts may be ...
Full textLink to itemCite
Journal ArticleJ Card Fail · June 2006
BACKGROUND: In human heart failure, increased expression of G protein-coupled receptor kinases (GRKs) causes the loss of beta-adrenergic receptor (betaAR) signaling and function. Mechanical unloading with a left ventricular assist device (LVAD) promotes re ...
Full textLink to itemCite
Journal ArticleInteract Cardiovasc Thorac Surg · June 2006
Microwave energy allows thoracoscopic beating-heart ablation for the treatment of atrial fibrillation. However, there is a paucity of data on the histologic effects of microwave energy on the beating human heart. This study aims to histopathologically char ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2006
Passive ventricular restraint devices, such as the ACORN CorCap, have been introduced as a potential therapy for congestive heart failure (CHF). These mesh devices act as a mechanical support for the dilated heart. Due to incorporation of the device to the ...
Full textLink to itemCite
Journal ArticleAnesth Analg · January 2006
Although the pathogenesis of acute renal injury after cardiac surgery is multifactorial, atherosclerosis of the ascending aorta and embolic burden are strong independent predictors. Use of the Symmetry aortic connector device (ACD) for proximal anastomosis ...
Full textLink to itemCite
Journal ArticleN C Med J · 2006
INTRODUCTION: Recently, the Food and Drug Administration approved implantable left ventricular assist devices (LVAD) as destination therapy (DT) for end-stage heart failure patients who are ineligible for cardiac transplantation. OBJECTIVE AND STUDY DESIGN ...
Link to itemCite
Journal ArticleAm J Cardiol · November 1, 2005
Up to 20% of saphenous vein grafts (SVGs) fail within 2 years of coronary artery bypass grafting (CABG). The long-term effects of early SVG failure on major clinical events remain undefined in contemporary patient populations. We sought to examine the rela ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 2005
We present the case of a young man who received a left ventricular assist device (LVAD) as a bridge to transplantation for end-stage heart failure, in whom the diagnosis of sarcoid cardiomyopathy was made at the time of LVAD implantation. He subsequently u ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · November 2005
BACKGROUND: Heart transplantation (HT) is an effective therapy for end-stage heart failure, but its impact is limited by the scarcity of donor organs and stringent selection criteria for both donors and recipients. The creation of an alternate list to matc ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · November 1, 2005
OBJECTIVES: The purpose of this study was to determine the value of a new anatomic score for prognosis after diagnostic catheterization in patients with previous coronary artery bypass grafting (CABG). BACKGROUND: Previous CABG patients comprise a growing ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2005
BACKGROUND: The utility of mitral valve repair (MV repair) has been well documented in patients with normal left ventricular function. Few studies, however, have specifically examined outcomes of isolated MV repair in patients with decreased left ventricul ...
Full textLink to itemCite
Journal ArticleCirculation · August 30, 2005
BACKGROUND: Surgeons have adopted off-pump coronary artery bypass grafting (OPCAB) in an effort to reduce the morbidity of surgical revascularization. However, long-term outcome of OPCAB compared with conventional coronary artery bypass grafting (CABG) rem ...
Full textLink to itemCite
Journal ArticleCirculation · August 30, 2005
BACKGROUND: It is unclear if mild or moderate mitral valve regurgitation (MR) should be repaired at the time of coronary artery bypass grafting (CABG). We sought to determine the long-term effect of uncorrected MR, measured by intraoperative transesophagea ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2005
Doxorubicin-induced cardiomyopathy is not uncommon and may progress to end-stage heart failure. Treatment of this condition with heart transplantation, however, requires that the primary malignancy be deemed "cured." We present the case of a 55- year-old w ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · June 2005
OBJECTIVES: Fifty percent of human aortocoronary saphenous vein grafts are occluded after 10 years. Intimal hyperplasia is an initial step in graft occlusion and consists of vascular smooth muscle cell proliferation. Phosphatidylinositol 3-kinase and its d ...
Full textLink to itemCite
Journal ArticleClin Chim Acta · June 2005
BACKGROUND: The activated clotting time (ACT) is a standard monitor for heparin anticoagulation during cardiopulmonary bypass (CPB). This study determines the effect of upgrading our ACT system on our clinical practice with regards to the conduct and safet ...
Full textLink to itemCite
Journal ArticleCirculation · May 24, 2005
BACKGROUND: Desensitization and downregulation of myocardial beta-adrenergic receptors (betaARs) are initiated by the increase in betaAR kinase 1 (betaARK1) levels. By interacting with betaARK1 through the phosphoinositide kinase (PIK) domain, phosphoinosi ...
Full textLink to itemCite
Journal ArticleAm J Kidney Dis · March 2005
BACKGROUND: Post-cardiac surgery renal dysfunction is a common, serious, multifactorial disorder, with interpatient variability predicted poorly by preoperative clinical, procedural, and biological markers. Therefore, we tested the hypothesis that selected ...
Full textLink to itemCite
Chapter · January 1, 2005
Careful assessment of end-organ dysfunction is critical in the evaluation of patients with AHF. Neurological function is the most important assessment. Devastating neurological injury is not uncommon, particularly in the setting of cardiac arrest, prolonge ...
Full textCite
Journal ArticleAnn Plast Surg · January 2005
Coronary artery bypass grafting is a common surgical procedure for myocardial revascularization. This operation usually involves the use of the left internal mammary artery to bypass the left anterior descending coronary artery. The internal mammary artery ...
Full textLink to itemCite
Journal ArticleCongest Heart Fail · 2005
The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial demonstrated increased 1- and 2-year survival and improved quality of life for end-stage heart failure patients implanted with the HeartMate VE ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · December 2004
OBJECTIVE: Heart surgery is associated with impairment of the myocardial beta-adrenoceptor (betaAR) system. Effective therapies for post-operative ventricular dysfunction are limited. Prolonged inotrope exposure is associated with further betaAR down-regul ...
Full textLink to itemCite
Journal ArticleJ Surg Res · November 2004
BACKGROUND: Adenoviral-mediated gene transfer during cardiopulmonary bypass (CPB) achieves efficient myocardial transgene expression. The optimal vector dose required to produce not only increased beta adrenoceptor (betaAR) density but, more importantly, e ...
Full textLink to itemCite
Journal ArticleArterioscler Thromb Vasc Biol · October 2004
OBJECTIVE: Fulfilling the promise of personalized medicine by developing individualized diagnostic and therapeutic strategies for atherosclerosis will depend on a detailed understanding of the genes and gene variants that contribute to disease susceptibili ...
Full textLink to itemCite
Journal ArticleJ Extra Corpor Technol · September 2004
Given the shortages of banked blood, the risks of transfusion reactions, disease transmissions, and transfusion errors, we perfusionists must find ways to avoid blood transfusions. At the end of any given bypass run, there is residual blood left in the byp ...
Link to itemCite
Journal ArticleAnn Thorac Surg · August 2004
BACKGROUND: Renal dysfunction is a serious complication of cardiac surgery that is highly associated with short- and long-term adverse outcome. While the apolipoprotein E (APOE) epsilon4 allele has been linked to the occurrence of both postcardiac surgery ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · August 2004
OBJECTIVE: To identify the demographic, clinical, and echocardiographic features that predict the use of inotropic support at separation from cardiopulmonary bypass (CPB). DESIGN: Retrospective study of consecutive patients undergoing coronary artery bypas ...
Full textLink to itemCite
Journal ArticleAnesth Analg · May 2004
UNLABELLED: Cardiac surgery results in significant impairment of beta-adrenergic receptor (beta AR) function and is a cause of depressed myocardial function after surgery. We previously demonstrated that acute administration of beta AR blocker during cardi ...
Full textLink to itemCite
Journal ArticleCirculation · April 6, 2004
BACKGROUND: Failing human myocardium is characterized by an attenuated contractile response to beta-adrenergic receptor (betaAR) stimulation due to changes in this signaling cascade, including increased expression and activity of the beta-adrenergic recept ...
Full textLink to itemCite
OtherJ Thorac Cardiovasc Surg · April 2004
OBJECTIVES: The extracellular signal-regulated kinase pathway of the mitogen-activated protein kinase signal transduction cascade has been implicated in the neuronal and endothelial dysfunction witnessed following cerebral ischemia-reperfusion injury. Extr ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · January 2004
OBJECTIVE: More than 50% of aortocoronary saphenous vein grafts are occluded 10 years after surgery. Intimal hyperplasia is an initial, critical step in the progression toward occlusion. To date, no clinically relevant large animal models of aortocoronary ...
Full textLink to itemCite
Journal ArticleClin Transpl · 2004
Since beginning cardiac transplantation in 1985, Duke University Medical Center has performed 485 de novo heart transplants in adult recipients. Our program has broadened the access of patients to transplantation through the aggressive use of ventricular a ...
Link to itemCite
OtherJ Thorac Cardiovasc Surg · December 2003
OBJECTIVES: Elevated levels of C-reactive protein are one of the strongest prognostic factors in atherosclerosis. In addition to predicting vascular disease, C-reactive protein may directly facilitate the development of a proinflammatory and proatheroscler ...
Full textLink to itemCite
OtherBr J Anaesth · November 2003
BACKGROUND: Aortic atheromatous disease is known to be associated with an increased risk of perioperative stroke in the setting of cardiac surgery. In this study, we sought to determine the relationship between cerebral microemboli and aortic atheroma burd ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · August 2003
OBJECTIVE: This study examines short-term mechanical assist device support for cardiac transplant patients and compares their outcomes with nontransplant patients requiring similar support. METHODS: Of 350 cardiac transplant patients at our institution, 7 ...
Full textLink to itemCite
Journal ArticleJ Am Coll Cardiol · April 2, 2003
OBJECTIVES: We sought to determine whether mechanical unloading of the failing human heart with a left ventricular assist device (LVAD) results in significant changes in overall left ventricular gene expression. BACKGROUND: Mechanical circulatory support b ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2003
Severely elevated pulmonary vascular resistance (PVR) is a relative contraindication to orthotopic heart transplantation. A potential novel strategy to reverse elevated PVR may be implantation of a chronic left ventricular assist device with subsequent lef ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2003
Paroxysmal cold hemoglobinuria, a cold-reactive autoimmune disease associated with the Donath-Landsteiner antibody, has not been described in patients undergoing cardiac surgery. We report a case of mitral valve replacement in a woman with a positive Donat ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · October 2002
Featured Publication
Aprotinin has been shown to reduce transfusion requirements in re-operative cardiac surgery and in implantation of long-term left ventricular assist devices (LVAD). However, it is an antigenic polypeptide and re-exposure is associated with a small incidenc ...
Full textLink to itemCite
OtherAnesth Analg · July 2002
UNLABELLED: Renal dysfunction is common after coronary artery bypass graft (CABG) surgery. We have previously shown that CABG procedures complicated by stroke have a threefold greater peak serum creatinine level relative to uncomplicated surgery. However, ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · May 2002
Featured Publication
OBJECTIVE: Adenoviral gene transfer to the arrested heart during cardiopulmonary bypass (CPB) is a novel method of allowing prolonged vector contact with the myocardium. In this model we investigated the importance of temperature, duration of arrest and ca ...
Full textLink to itemCite
OtherAnesth Analg · January 2002
UNLABELLED: Neurocognitive dysfunction is a common complication after cardiac surgery. We evaluated in this prospective study the effect of rewarming rate on neurocognitive outcome after hypothermic cardiopulmonary bypass (CPB). After IRB approval and info ...
Full textLink to itemCite
Journal ArticleCirculation · July 10, 2001
Featured Publication
BACKGROUND: Cardiac gene therapy offers the possibility of enhancing myocardial performance in the compromised heart. However, current gene delivery techniques have limited myocardial transgene expression and pose the risk of extracardiac expression. Isola ...
Full textLink to itemCite
Journal ArticleAm Heart J · November 2000
OBJECTIVE: Previous studies have been inconsistent in defining a clinical benefit to the bicaval cardiac transplantation technique relative to the standard technique, and many major centers have not adopted this newer approach. The purpose of this study wa ...
Full textLink to itemCite
Journal ArticleCardiovasc Surg · June 2000
An anomalous right coronary artery arising from the left sinus of Valsalva is a rare but potentially lethal abnormality. We present a case report and literature review of this anomaly as well as its surgical management in the face of unobstructed distal co ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 1999
BACKGROUND: Pectoralis flaps are frequently used to treat poststernotomy mediastinitis. We compared the outcomes of omental transfer, an alternative treatment for mediastinitis, with those of pectoralis flaps. METHODS: Patients treated for poststernotomy m ...
Full textLink to itemCite
Journal ArticleClin Transpl · 1999
More than 1,200 patients have now undergone thoracic transplantation at Papworth Hospital and about 90 transplants are performed annually. Papworth remains one of the largest transplant units in the UK. Unique activities include a very large heart-lung tra ...
Link to itemCite
Journal ArticleCirc Res · December 14, 1998
Reperfusion of globally ischemic rat hearts causes the generation of inositol(1,4,5)trisphosphate [Ins(1,4,5)P3] and the initiation of arrhythmias. These responses are mediated by alpha1-adrenergic receptors (ARs), but the subtype of receptor involved has ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 1998
OBJECTIVE: To elucidate the causes of cardiovascular hemorrhage associated with mediastinitis and to review recommendations for prevention and treatment. SUMMARY BACKGROUND DATA: Mediastinal debridement with immediate or early coverage using healthy, vascu ...
Full textLink to itemCite
Journal ArticleJ Biol Chem · August 22, 1997
Transgenic mice were generated with cardiac-specific overexpression of the wild-type (WT) alpha1B-adrenergic receptor (AR) using the murine alpha-myosin heavy chain gene promoter. Previously, we described transgenic mice with alpha-myosin heavy chain-direc ...
Full textLink to itemCite
Journal ArticleJ Card Fail · March 1997
BACKGROUND: Recent experiments have documented the importance of beta-adrenergic regulation of the force-frequency relation (FFR) in the normal and failing heart. As in isolated human cardiac muscle, a descending limb of the FFR occurs at high frequencies ...
Full textLink to itemCite
Journal ArticleJ Mol Cell Cardiol · March 1997
Transgenic mice overexpressing the human beta 2-adrenergic receptor gene were compared with wild mice type in terms of cardiac function, using a modified work-performing isolated murine heart preparation and on-line computer analysis. A preload-dependent e ...
Full textLink to itemCite
Journal ArticleProc Natl Acad Sci U S A · January 7, 1997
Transgenic overexpression (40- to 100-fold) of the wild-type human beta2-adrenergic receptor in the hearts of mice leads to a marked increase in cardiac contractility, which is apparently due to the low level of spontaneous (i.e., agonist-independent) acti ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Mol Med (Berl) · September 1996
Heart failure is a problem of increasing importance in cardiovascular medicine. An important characteristic of heart failure is reduced agonist-stimulated adenylyl cyclase activity (receptor desensitization) due to both diminished receptor number (receptor ...
Full textLink to itemCite
Journal ArticleAm J Physiol · August 1996
Transgenic mice have been created with 200-fold overexpression of beta 2-adrenergic receptors specifically in the heart. Cardiac function was studied in these transgenic mice and their controls at baseline and during isoproterenol perfusion or sympathetic ...
Full textLink to itemCite
Journal ArticleJ Clin Invest · April 1, 1996
To assess the effect of targeted myocardial beta-adrenergic receptor (AR) stimulation on relaxation and phospholamban regulation, we studied the physiological and biochemical alterations associated with overexpression of the human beta2-AR gene in transgen ...
Full textOpen AccessLink to itemCite
Journal ArticleCirculation · October 15, 1995
BACKGROUND: Mediastinitis is a severe complication of coronary artery bypass graft surgery (CABG). The purpose of the present study was to determine preoperative and intraoperative variables that predict mediastinitis and to determine the impact of this co ...
Full textLink to itemCite
Journal ArticleScience · June 2, 1995
Transgenic mice were created with cardiac-specific overexpression of the beta-adrenergic receptor kinase-1 (beta ARK1) or a beta ARK inhibitor. Animals overexpressing beta ARK1 demonstrated attenuation of isoproterenol-stimulated left ventricular contracti ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 1995
OBJECTIVE: Right ventricular (RV) dysfunction remains the leading cause of early mortality after cardiac transplantation. The effect of brain death and subsequent hypothermic cardioplegic arrest and storage on subsequent post-transplant right ventricular f ...
Full textLink to itemCite
Journal ArticleNature · March 16, 1995
G-protein-coupled receptors are thought to have an inactive conformation (R), requiring an agonist-induced conformational change for receptor/G-protein coupling. But new evidence suggests a two-state model in which receptors are in equilibrium between the ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 1995
Transgenic mice with intense cardiac expression of a human beta-adrenergic receptor gene were engineered and shown to display marked improvements in baseline myocardial and left ventricular function. Heart/body weight ratios and histologic appearance were ...
Full textLink to itemCite
Journal ArticleCirculation · November 1994
BACKGROUND: Procedure-related costs are of increasing concern in selecting the appropriate procedure for the treatment of coronary artery disease (CAD). METHODS AND RESULTS: To determine what preoperative factors influence total postoperative hospital cost ...
Link to itemCite
Journal ArticleProc Natl Acad Sci U S A · October 11, 1994
Transgenic mice were generated by using the alpha-myosin heavy chain promoter coupled to the coding sequence of a constitutively active mutant alpha 1B-adrenergic receptor (AR). These transgenic animals demonstrated cardiac-specific expression of this alph ...
Full textOpen AccessLink to itemCite
Journal ArticleScience · April 22, 1994
Transgenic mice were created with cardiac-specific overexpression of the beta 2-adrenergic receptor. This resulted in increased basal myocardial adenylyl cyclase activity, enhanced atrial contractility, and increased left ventricular function in vivo; thes ...
Full textLink to itemCite
Journal ArticleCirculation · November 1993
BACKGROUND: To identify the determinants of survival in patients with severe (> 75%) stenosis of the left main coronary artery (LM) and an acute (48 hours) anterolateral myocardial infarction (AAMI), we retrospectively analyzed the course of 34 such patien ...
Link to itemCite
Journal ArticleAnn Thorac Surg · September 1993
This study evaluates whether patients with coronary artery disease and severely depressed left ventricular ejection fraction benefit from coronary artery bypass grafting. From 1981 to 1991, 118 consecutive patients with ejection fraction less than or equal ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · September 1, 1992
Although coronary artery bypass grafting (CABG) effectively eliminates or diminishes symptoms of myocardial ischemia, the overall performance status and functional outcome in elderly patients undergoing CABG is poorly documented. Therefore, 86 consecutive ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg
Arterial cannulation for veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) is most commonly established via the aorta, axillary, or femoral vessels, yet their inherent complications are not well characterized. The purpose of this study was to c ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg
Utilization of extracorporeal membrane oxygenation (ECMO) has increased dramatically over the last decade. Despite this trend, many medical centers have limited, if any, access to this technology or the resources necessary to manage these complex patients. ...
Full textLink to itemCite